Arianne Clinical Research Algeria – Cellia Habita, President and CEO
05.01.2015
Related Interviews
Italy / Gilead's Valentino Confalone on Eliminating Viral Hepatitis by 2030, HIV Pipeline Potential, & the Future of CAR-T
Gilead Sciences’ vice president and general manager for Italy, Valentino Confalone, outlines the company’s tumultuous pandemic journey in one of the first global epicentres; the role that Italy played in…
Mohamed Mostafa – Vice President and General Manager Saudi Arabia &…
IQVIA Vice President and General Manager Saudi Arabia & Egypt Mohamed Mostafa gives his expert insights into the transformation of the Saudi pharma market in recent years, covering everything from…
Italy / Gilead's Valentino Confalone on Eliminating Viral Hepatitis by 2030, HIV Pipeline Potential, & the Future of CAR-T
Can you begin by commenting on Gilead’s footprint in Italy, a country where the company has been present for just two decades? Even though it is relatively young, Gilead is…
Spain / 5 Key Industry Trends 2021
According to recent IQVIA and industry association reports, the Spanish pharma market, valued at EUR 21.6 billion per year, continues to grow at a relatively slow pace. Other key trends…
Catalonia / 5 Things to Know
A rundown of five things to know about the healthcare and life sciences industry in Catalonia. Nestled in Northeastern Spain and bordering France, Catalonia’s capital and largest city is Barcelona.…
Nordics / Danish-Swedish Clinical Trial Collaboration: Better Together?
Denmark boasts plenty of strong fundamentals as a clinical trials hub, but is perhaps constrained by a population of just 5.8 million and a correspondingly small patient pool. However, international…
